Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma, M. Sacco, Brett L. Hurst, Julia A. Townsend, Yanmei Hu, Tommy Szeto, Xiujun Zhang, E. Bart Tarbet, Michael T. Marty, Yu Chen, Jun Wang
Topics & Concepts
BoceprevirBiologyVirologyProteaseViral replicationCalpainSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Replication (statistics)Coronavirus disease 2019 (COVID-19)EnzymeVirusRibavirinBiochemistryInfectious disease (medical specialty)Hepatitis C virusMedicinePathologyDiseaseSARS-CoV-2 and COVID-19 Researchinterferon and immune responsesCalpain Protease Function and Regulation